We support investigators and sponsors throughout the CDSCO regulatory submission process by coordinating required documentation, ensuring alignment with current Indian regulatory guidelines, and facilitating timely submissions. Our team stays updated with CDSCO requirements to minimize delays and ensure smooth study approvals.

Med Express has extensive experience working with Institutional Ethics Committees (IECs) across India. We assist with ethics submissions, responses to committee queries, protocol amendments, and continuing reviews, ensuring ethical oversight and patient safety throughout the study lifecycle.

We leverage strong relationships with local investigators, hospitals, and communities in tier-2 cities. Our patient-centric recruitment strategies focus on ethical engagement, awareness initiatives, and efficient screening to achieve enrollment targets without compromising quality or compliance.

We ensure strict adherence to ICH-GCP guidelines and applicable Indian regulations through trained site coordinators, standardized SOPs, and regular internal reviews. Our approach emphasizes data integrity, regulatory compliance, and patient safety across all trial sites.

Yes, we support both single-center and multi-center clinical trials across multiple regions in India. Our centralized coordination model ensures consistent site operations, standardized processes, and effective communication across all participating sites.

We act as a coordination bridge between investigators, sponsors, and CROs by facilitating regular updates, supporting monitoring and audit visits, and resolving operational queries promptly. This ensures transparency, timely issue resolution, and smooth study progress.